#FORMAT=WebAnno TSV 3.2
#T_SP=webanno.custom.Referent|entity|infstat
#T_RL=webanno.custom.Coref|type|BT_webanno.custom.Referent


#Text=1. Introduction
1-1	0-2	1.	_	_	_	_
1-2	3-15	Introduction	abstract	new	_	_

#Text=Maize is grown worldwide , with the United States , China , and Brazil ranked as the leading producing countries contributing approximately 563 of the 717 million metric tonnes per year .
2-1	16-21	Maize	plant	new	coref	3-3
2-2	22-24	is	_	_	_	_
2-3	25-30	grown	_	_	_	_
2-4	31-40	worldwide	_	_	_	_
2-5	41-42	,	_	_	_	_
2-6	43-47	with	_	_	_	_
2-7	48-51	the	place[3]	new[3]	_	_
2-8	52-58	United	place[3]	new[3]	_	_
2-9	59-65	States	place[3]	new[3]	_	_
2-10	66-67	,	_	_	_	_
2-11	68-73	China	place	new	_	_
2-12	74-75	,	_	_	_	_
2-13	76-79	and	_	_	_	_
2-14	80-86	Brazil	place	new	_	_
2-15	87-93	ranked	_	_	_	_
2-16	94-96	as	_	_	_	_
2-17	97-100	the	place[6]	new[6]	_	_
2-18	101-108	leading	place[6]	new[6]	_	_
2-19	109-118	producing	place[6]	new[6]	_	_
2-20	119-128	countries	place[6]	new[6]	_	_
2-21	129-141	contributing	place[6]	new[6]	_	_
2-22	142-155	approximately	place[6]|abstract[7]	new[6]|new[7]	_	_
2-23	156-159	563	place[6]|abstract[7]	new[6]|new[7]	_	_
2-24	160-162	of	place[6]|abstract[7]	new[6]|new[7]	_	_
2-25	163-166	the	place[6]|abstract[7]|substance[8]	new[6]|new[7]|new[8]	_	_
2-26	167-170	717	place[6]|abstract[7]|substance[8]	new[6]|new[7]|new[8]	_	_
2-27	171-178	million	place[6]|abstract[7]|substance[8]	new[6]|new[7]|new[8]	_	_
2-28	179-185	metric	place[6]|abstract[7]|substance[8]	new[6]|new[7]|new[8]	_	_
2-29	186-192	tonnes	place[6]|abstract[7]|substance[8]	new[6]|new[7]|new[8]	_	_
2-30	193-196	per	place[6]|abstract[7]|substance[8]	new[6]|new[7]|new[8]	_	_
2-31	197-201	year	place[6]|abstract[7]|substance[8]|time	new[6]|new[7]|new[8]|new	_	_
2-32	202-203	.	_	_	_	_

#Text=However , maize , like other cereals , is susceptible to contamination by mycotoxins , including T-2 toxin .
3-1	204-211	However	_	_	_	_
3-2	212-213	,	_	_	_	_
3-3	214-219	maize	plant	giv	coref	4-17
3-4	220-221	,	_	_	_	_
3-5	222-226	like	_	_	_	_
3-6	227-232	other	plant[11]	new[11]	_	_
3-7	233-240	cereals	plant[11]	new[11]	_	_
3-8	241-242	,	_	_	_	_
3-9	243-245	is	_	_	_	_
3-10	246-257	susceptible	_	_	_	_
3-11	258-260	to	_	_	_	_
3-12	261-274	contamination	abstract[12]	new[12]	_	_
3-13	275-277	by	abstract[12]	new[12]	_	_
3-14	278-288	mycotoxins	abstract[12]|substance[13]	new[12]|new[13]	coref	6-8[41_13]
3-15	289-290	,	abstract[12]|substance[13]	new[12]|new[13]	_	_
3-16	291-300	including	abstract[12]|substance[13]	new[12]|new[13]	_	_
3-17	301-304	T-2	abstract[12]|substance[13]|substance|substance[15]	new[12]|new[13]|new|new[15]	coref|coref	4-1|4-1[17_15]
3-18	305-310	toxin	abstract[12]|substance[13]|substance[15]	new[12]|new[13]|new[15]	_	_
3-19	311-312	.	_	_	_	_

#Text=T-2 toxin is common in grains , including oats , soybeans , rice , barley , maize , and wheat .
4-1	313-316	T-2	substance|substance[17]	giv|giv[17]	coref|coref	5-25|5-25[38_17]
4-2	317-322	toxin	substance[17]	giv[17]	_	_
4-3	323-325	is	_	_	_	_
4-4	326-332	common	_	_	_	_
4-5	333-335	in	_	_	_	_
4-6	336-342	grains	substance[18]	new[18]	_	_
4-7	343-344	,	substance[18]	new[18]	_	_
4-8	345-354	including	substance[18]	new[18]	_	_
4-9	355-359	oats	substance[18]|plant	new[18]|new	_	_
4-10	360-361	,	substance[18]	new[18]	_	_
4-11	362-370	soybeans	substance[18]|substance	new[18]|new	_	_
4-12	371-372	,	substance[18]	new[18]	_	_
4-13	373-377	rice	substance[18]|substance	new[18]|new	_	_
4-14	378-379	,	substance[18]	new[18]	_	_
4-15	380-386	barley	substance[18]|object	new[18]|new	_	_
4-16	387-388	,	substance[18]	new[18]	_	_
4-17	389-394	maize	substance[18]|plant	new[18]|giv	_	_
4-18	395-396	,	substance[18]	new[18]	_	_
4-19	397-400	and	substance[18]	new[18]	_	_
4-20	401-406	wheat	substance[18]|plant	new[18]|new	_	_
4-21	407-408	.	_	_	_	_

#Text=Fusarium langsethiae and F. sporotrichioides are some of the Fusarium species that infect crops in the field and storage during which time they produce T-2 toxin .
5-1	409-417	Fusarium	place|abstract[26]	new|new[26]	coref	5-10
5-2	418-429	langsethiae	abstract[26]	new[26]	_	_
5-3	430-433	and	_	_	_	_
5-4	434-436	F.	person|plant[28]	new|new[28]	coref|coref	6-17[0_28]|6-19[46_0]
5-5	437-453	sporotrichioides	plant[28]	new[28]	_	_
5-6	454-457	are	_	_	_	_
5-7	458-462	some	_	_	_	_
5-8	463-465	of	_	_	_	_
5-9	466-469	the	plant[30]	new[30]	_	_
5-10	470-478	Fusarium	place|plant[30]	giv|new[30]	coref	6-16
5-11	479-486	species	plant[30]	new[30]	_	_
5-12	487-491	that	plant[30]	new[30]	_	_
5-13	492-498	infect	plant[30]	new[30]	_	_
5-14	499-504	crops	plant[30]|plant	new[30]|new	_	_
5-15	505-507	in	plant[30]	new[30]	_	_
5-16	508-511	the	plant[30]|place[32]|place[33]	new[30]|new[32]|new[33]	ana	5-23[0_33]
5-17	512-517	field	plant[30]|place[32]|place[33]	new[30]|new[32]|new[33]	_	_
5-18	518-521	and	plant[30]|place[33]	new[30]|new[33]	_	_
5-19	522-529	storage	plant[30]|place[33]|place	new[30]|new[33]|new	_	_
5-20	530-536	during	plant[30]	new[30]	_	_
5-21	537-542	which	plant[30]|time[35]	new[30]|new[35]	_	_
5-22	543-547	time	plant[30]|time[35]	new[30]|new[35]	_	_
5-23	548-552	they	place	giv	_	_
5-24	553-560	produce	_	_	_	_
5-25	561-564	T-2	substance|substance[38]	giv|giv[38]	coref|coref	6-1[39_38]|7-17
5-26	565-570	toxin	substance[38]	giv[38]	_	_
5-27	571-572	.	_	_	_	_

#Text=This toxin belongs to the family of mycotoxins known as the trichothecenes produced mainly by Fusarium sporotrichioides , F. graminearum , F. poae , and F. culmorum and causing diarrhea , inflammation , and emesis .
6-1	573-577	This	substance[39]	giv[39]	coref	7-17[60_39]
6-2	578-583	toxin	substance[39]	giv[39]	_	_
6-3	584-591	belongs	_	_	_	_
6-4	592-594	to	_	_	_	_
6-5	595-598	the	abstract[40]	new[40]	_	_
6-6	599-605	family	abstract[40]	new[40]	_	_
6-7	606-608	of	abstract[40]	new[40]	_	_
6-8	609-619	mycotoxins	abstract[40]|substance[41]	new[40]|giv[41]	coref	8-4[66_41]
6-9	620-625	known	abstract[40]|substance[41]	new[40]|giv[41]	_	_
6-10	626-628	as	abstract[40]|substance[41]	new[40]|giv[41]	_	_
6-11	629-632	the	abstract[40]|substance[41]|abstract[42]	new[40]|giv[41]|new[42]	_	_
6-12	633-647	trichothecenes	abstract[40]|substance[41]|abstract[42]	new[40]|giv[41]|new[42]	_	_
6-13	648-656	produced	abstract[40]|substance[41]|abstract[42]	new[40]|giv[41]|new[42]	_	_
6-14	657-663	mainly	abstract[40]|substance[41]|abstract[42]	new[40]|giv[41]|new[42]	_	_
6-15	664-666	by	abstract[40]|substance[41]|abstract[42]	new[40]|giv[41]|new[42]	_	_
6-16	667-675	Fusarium	abstract[40]|substance[41]|abstract[42]|place	new[40]|giv[41]|new[42]|giv	_	_
6-17	676-692	sporotrichioides	abstract[40]|substance[41]|abstract[42]|plant|plant[45]	new[40]|giv[41]|new[42]|giv|giv[45]	coref	6-17[45_0]
6-18	693-694	,	abstract[40]|substance[41]|abstract[42]|plant[45]	new[40]|giv[41]|new[42]|giv[45]	_	_
6-19	695-697	F.	abstract[40]|substance[41]|abstract[42]|plant[45]|person[46]	new[40]|giv[41]|new[42]|giv[45]|giv[46]	coref	6-22[47_46]
6-20	698-709	graminearum	abstract[40]|substance[41]|abstract[42]|plant[45]|person[46]	new[40]|giv[41]|new[42]|giv[45]|giv[46]	_	_
6-21	710-711	,	abstract[40]|substance[41]|abstract[42]|plant[45]	new[40]|giv[41]|new[42]|giv[45]	_	_
6-22	712-714	F.	abstract[40]|substance[41]|abstract[42]|plant[45]|person[47]	new[40]|giv[41]|new[42]|giv[45]|giv[47]	coref	6-26[48_47]
6-23	715-719	poae	abstract[40]|substance[41]|abstract[42]|plant[45]|person[47]	new[40]|giv[41]|new[42]|giv[45]|giv[47]	_	_
6-24	720-721	,	abstract[40]|substance[41]|abstract[42]|plant[45]	new[40]|giv[41]|new[42]|giv[45]	_	_
6-25	722-725	and	abstract[40]|substance[41]|abstract[42]|plant[45]	new[40]|giv[41]|new[42]|giv[45]	_	_
6-26	726-728	F.	abstract[40]|substance[41]|abstract[42]|plant[45]|person[48]	new[40]|giv[41]|new[42]|giv[45]|giv[48]	_	_
6-27	729-737	culmorum	abstract[40]|substance[41]|abstract[42]|plant[45]|person[48]	new[40]|giv[41]|new[42]|giv[45]|giv[48]	_	_
6-28	738-741	and	abstract[40]|substance[41]|abstract[42]	new[40]|giv[41]|new[42]	_	_
6-29	742-749	causing	abstract[40]|substance[41]|abstract[42]	new[40]|giv[41]|new[42]	_	_
6-30	750-758	diarrhea	abstract[40]|substance[41]|abstract[42]|place|abstract[50]	new[40]|giv[41]|new[42]|new|new[50]	ana	7-1[0_50]
6-31	759-760	,	abstract[40]|substance[41]|abstract[42]|abstract[50]	new[40]|giv[41]|new[42]|new[50]	_	_
6-32	761-773	inflammation	abstract[40]|substance[41]|abstract[42]|abstract[50]|event	new[40]|giv[41]|new[42]|new[50]|new	coref	16-15[110_0]
6-33	774-775	,	abstract[40]|substance[41]|abstract[42]|abstract[50]	new[40]|giv[41]|new[42]|new[50]	_	_
6-34	776-779	and	abstract[40]|substance[41]|abstract[42]|abstract[50]	new[40]|giv[41]|new[42]|new[50]	_	_
6-35	780-786	emesis	abstract[40]|substance[41]|abstract[42]|abstract[50]|abstract	new[40]|giv[41]|new[42]|new[50]|new	_	_
6-36	787-788	.	_	_	_	_

#Text=They can be grouped into Type A , B , C , and D , with T-2 toxin belonging to Type A trichothecenes , the most toxic group of trichothecenes .
7-1	789-793	They	abstract	giv	_	_
7-2	794-797	can	_	_	_	_
7-3	798-800	be	_	_	_	_
7-4	801-808	grouped	_	_	_	_
7-5	809-813	into	_	_	_	_
7-6	814-818	Type	abstract|place[55]	new|new[55]	coref	7-21[61_55]
7-7	819-820	A	place[55]	new[55]	_	_
7-8	821-822	,	_	_	_	_
7-9	823-824	B	place	new	_	_
7-10	825-826	,	_	_	_	_
7-11	827-828	C	person	new	_	_
7-12	829-830	,	_	_	_	_
7-13	831-834	and	_	_	_	_
7-14	835-836	D	abstract	new	_	_
7-15	837-838	,	_	_	_	_
7-16	839-843	with	_	_	_	_
7-17	844-847	T-2	substance|substance[60]	giv|giv[60]	coref|coref	9-2|11-5[90_60]
7-18	848-853	toxin	substance[60]	giv[60]	_	_
7-19	854-863	belonging	substance[60]	giv[60]	_	_
7-20	864-866	to	substance[60]	giv[60]	_	_
7-21	867-871	Type	substance[60]|place[61]	giv[60]|giv[61]	_	_
7-22	872-873	A	substance[60]|place[61]	giv[60]|giv[61]	_	_
7-23	874-888	trichothecenes	substance[60]|abstract	giv[60]|new	coref	7-30
7-24	889-890	,	_	_	_	_
7-25	891-894	the	person[63]	new[63]	coref	9-16[74_63]
7-26	895-899	most	person[63]	new[63]	_	_
7-27	900-905	toxic	person[63]	new[63]	_	_
7-28	906-911	group	person[63]	new[63]	_	_
7-29	912-914	of	person[63]	new[63]	_	_
7-30	915-929	trichothecenes	person[63]|abstract	new[63]|giv	coref	8-1
7-31	930-931	.	_	_	_	_

#Text=Trichothecenes are among the mycotoxins associated with human and veterinary diseases .
8-1	932-946	Trichothecenes	abstract	giv	coref	9-4[69_0]
8-2	947-950	are	_	_	_	_
8-3	951-956	among	_	_	_	_
8-4	957-960	the	substance[66]	giv[66]	coref	22-23[0_66]
8-5	961-971	mycotoxins	substance[66]	giv[66]	_	_
8-6	972-982	associated	substance[66]	giv[66]	_	_
8-7	983-987	with	substance[66]	giv[66]	_	_
8-8	988-993	human	substance[66]|abstract[67]	giv[66]|new[67]	_	_
8-9	994-997	and	substance[66]|abstract[67]	giv[66]|new[67]	_	_
8-10	998-1008	veterinary	substance[66]|abstract[67]	giv[66]|new[67]	_	_
8-11	1009-1017	diseases	substance[66]|abstract[67]	giv[66]|new[67]	_	_
8-12	1018-1019	.	_	_	_	_

#Text=Like T-2 , all trichothecenes have a common tetracyclic sesquiterpenoid 12,13-epoxytrichothec-9-ene ring system together with an epoxide group located at their C12 , C13 positions , which accounts for their toxicity .
9-1	1020-1024	Like	_	_	_	_
9-2	1025-1028	T-2	substance	giv	coref	10-1
9-3	1029-1030	,	_	_	_	_
9-4	1031-1034	all	abstract[69]	giv[69]	ana	9-21[0_69]
9-5	1035-1049	trichothecenes	abstract[69]	giv[69]	_	_
9-6	1050-1054	have	_	_	_	_
9-7	1055-1056	a	abstract[72]	new[72]	coref	21-23[145_72]
9-8	1057-1063	common	abstract[72]	new[72]	_	_
9-9	1064-1075	tetracyclic	abstract[72]	new[72]	_	_
9-10	1076-1091	sesquiterpenoid	organization|abstract[72]	new|new[72]	_	_
9-11	1092-1119	12,13-epoxytrichothec-9-ene	abstract[72]	new[72]	_	_
9-12	1120-1124	ring	abstract|abstract[72]	new|new[72]	_	_
9-13	1125-1131	system	abstract[72]	new[72]	_	_
9-14	1132-1140	together	_	_	_	_
9-15	1141-1145	with	_	_	_	_
9-16	1146-1148	an	person[74]	giv[74]	_	_
9-17	1149-1156	epoxide	substance|person[74]	new|giv[74]	_	_
9-18	1157-1162	group	person[74]	giv[74]	_	_
9-19	1163-1170	located	person[74]	giv[74]	_	_
9-20	1171-1173	at	person[74]	giv[74]	_	_
9-21	1174-1179	their	person[74]|abstract|abstract[78]	giv[74]|giv|new[78]	ana	9-30
9-22	1180-1183	C12	person[74]|abstract|abstract[78]	giv[74]|new|new[78]	_	_
9-23	1184-1185	,	person[74]|abstract[78]	giv[74]|new[78]	_	_
9-24	1186-1189	C13	person[74]|place|abstract[78]	giv[74]|new|new[78]	_	_
9-25	1190-1199	positions	person[74]|abstract[78]	giv[74]|new[78]	_	_
9-26	1200-1201	,	person[74]|abstract[78]	giv[74]|new[78]	_	_
9-27	1202-1207	which	person[74]|abstract[78]	giv[74]|new[78]	_	_
9-28	1208-1216	accounts	person[74]|abstract[78]	giv[74]|new[78]	_	_
9-29	1217-1220	for	person[74]|abstract[78]	giv[74]|new[78]	_	_
9-30	1221-1226	their	person[74]|abstract[78]|abstract|abstract[80]	giv[74]|new[78]|giv|new[80]	coref	10-1[82_80]
9-31	1227-1235	toxicity	person[74]|abstract[78]|abstract[80]	giv[74]|new[78]|new[80]	_	_
9-32	1236-1237	.	_	_	_	_

#Text=T-2 toxicity is induced via oxidative stress-mediated deoxyribonucleic acid ( DNA ) damage and apoptosis .
10-1	1238-1241	T-2	substance|abstract[82]	giv|giv[82]	coref|coref	11-5|19-25[132_82]
10-2	1242-1250	toxicity	abstract[82]	giv[82]	_	_
10-3	1251-1253	is	_	_	_	_
10-4	1254-1261	induced	_	_	_	_
10-5	1262-1265	via	_	_	_	_
10-6	1266-1275	oxidative	substance[84]|event[86]	new[84]|new[86]	_	_
10-7	1276-1291	stress-mediated	abstract|substance[84]|event[86]	new|new[84]|new[86]	_	_
10-8	1292-1308	deoxyribonucleic	substance[84]|event[86]	new[84]|new[86]	_	_
10-9	1309-1313	acid	substance[84]|event[86]	new[84]|new[86]	_	_
10-10	1314-1315	(	event[86]	new[86]	_	_
10-11	1316-1319	DNA	abstract|event[86]	new|new[86]	_	_
10-12	1320-1321	)	event[86]	new[86]	_	_
10-13	1322-1328	damage	event[86]	new[86]	_	_
10-14	1329-1332	and	_	_	_	_
10-15	1333-1342	apoptosis	event	new	_	_
10-16	1343-1344	.	_	_	_	_

#Text=The chemical structure of T-2 toxin is shown in
11-1	1345-1348	The	abstract[88]	new[88]	_	_
11-2	1349-1357	chemical	abstract[88]	new[88]	_	_
11-3	1358-1367	structure	abstract[88]	new[88]	_	_
11-4	1368-1370	of	abstract[88]	new[88]	_	_
11-5	1371-1374	T-2	abstract[88]|substance|substance[90]	new[88]|giv|giv[90]	coref|coref	14-1|14-1[93_90]
11-6	1375-1380	toxin	abstract[88]|substance[90]	new[88]|giv[90]	_	_
11-7	1381-1383	is	_	_	_	_
11-8	1384-1389	shown	_	_	_	_
11-9	1390-1392	in	_	_	_	_

#Text=Figure 1
12-1	1393-1399	Figure	abstract[91]	new[91]	_	_
12-2	1400-1401	1	abstract[91]	new[91]	_	_

#Text=.
13-1	1402-1403	.	_	_	_	_

#Text=T-2 toxin is a recognized inhibitor of protein synthesis , which occurs by the binding of peptidyl transferase , present in the 60S ribosomal subunit .
14-1	1404-1407	T-2	substance|substance[93]	giv|giv[93]	coref|coref	14-4[94_93]|15-1
14-2	1408-1413	toxin	substance[93]	giv[93]	_	_
14-3	1414-1416	is	_	_	_	_
14-4	1417-1418	a	substance[94]	giv[94]	coref	16-1[106_94]
14-5	1419-1429	recognized	substance[94]	giv[94]	_	_
14-6	1430-1439	inhibitor	substance[94]	giv[94]	_	_
14-7	1440-1442	of	substance[94]	giv[94]	_	_
14-8	1443-1450	protein	substance[94]|substance|event[96]	giv[94]|new|new[96]	_	_
14-9	1451-1460	synthesis	substance[94]|event[96]	giv[94]|new[96]	_	_
14-10	1461-1462	,	substance[94]|event[96]	giv[94]|new[96]	_	_
14-11	1463-1468	which	substance[94]|event[96]	giv[94]|new[96]	_	_
14-12	1469-1475	occurs	substance[94]|event[96]	giv[94]|new[96]	_	_
14-13	1476-1478	by	substance[94]|event[96]	giv[94]|new[96]	_	_
14-14	1479-1482	the	substance[94]|event[96]|event[97]	giv[94]|new[96]|new[97]	_	_
14-15	1483-1490	binding	substance[94]|event[96]|event[97]	giv[94]|new[96]|new[97]	_	_
14-16	1491-1493	of	substance[94]|event[96]|event[97]	giv[94]|new[96]|new[97]	_	_
14-17	1494-1502	peptidyl	substance[94]|event[96]|event[97]|abstract|object[99]	giv[94]|new[96]|new[97]|new|new[99]	_	_
14-18	1503-1514	transferase	substance[94]|event[96]|event[97]|object[99]	giv[94]|new[96]|new[97]|new[99]	_	_
14-19	1515-1516	,	substance[94]|event[96]|event[97]|object[99]	giv[94]|new[96]|new[97]|new[99]	_	_
14-20	1517-1524	present	substance[94]|event[96]|event[97]|object[99]	giv[94]|new[96]|new[97]|new[99]	_	_
14-21	1525-1527	in	substance[94]|event[96]|event[97]|object[99]	giv[94]|new[96]|new[97]|new[99]	_	_
14-22	1528-1531	the	substance[94]|event[96]|event[97]|object[99]|object[100]	giv[94]|new[96]|new[97]|new[99]|new[100]	_	_
14-23	1532-1535	60S	substance[94]|event[96]|event[97]|object[99]|object[100]	giv[94]|new[96]|new[97]|new[99]|new[100]	_	_
14-24	1536-1545	ribosomal	substance[94]|event[96]|event[97]|object[99]|object[100]	giv[94]|new[96]|new[97]|new[99]|new[100]	_	_
14-25	1546-1553	subunit	substance[94]|event[96]|event[97]|object[99]|object[100]	giv[94]|new[96]|new[97]|new[99]|new[100]	_	_
14-26	1554-1555	.	_	_	_	_

#Text=T-2 poisoning in man results in alimentary toxic aleukia ( ATA ) .
15-1	1556-1559	T-2	substance|event[102]	giv|new[102]	coref	18-1
15-2	1560-1569	poisoning	event[102]	new[102]	_	_
15-3	1570-1572	in	event[102]	new[102]	_	_
15-4	1573-1576	man	event[102]|person	new[102]|new	_	_
15-5	1577-1584	results	_	_	_	_
15-6	1585-1587	in	_	_	_	_
15-7	1588-1598	alimentary	substance[104]	new[104]	_	_
15-8	1599-1604	toxic	substance[104]	new[104]	_	_
15-9	1605-1612	aleukia	substance[104]	new[104]	_	_
15-10	1613-1614	(	_	_	_	_
15-11	1615-1618	ATA	abstract	new	_	_
15-12	1619-1620	)	_	_	_	_
15-13	1621-1622	.	_	_	_	_

#Text=The toxin also causes ulcers as well as necrosis in the digestive tract , hemorrhagic inflammation , and dystrophy in the brain , heart , kidney , and liver .
16-1	1623-1626	The	substance[106]	giv[106]	coref	19-18[130_106]
16-2	1627-1632	toxin	substance[106]	giv[106]	_	_
16-3	1633-1637	also	_	_	_	_
16-4	1638-1644	causes	_	_	_	_
16-5	1645-1651	ulcers	abstract	new	_	_
16-6	1652-1654	as	_	_	_	_
16-7	1655-1659	well	_	_	_	_
16-8	1660-1662	as	_	_	_	_
16-9	1663-1671	necrosis	abstract[108]	new[108]	_	_
16-10	1672-1674	in	abstract[108]	new[108]	_	_
16-11	1675-1678	the	abstract[108]|object[109]	new[108]|new[109]	coref	21-11[142_109]
16-12	1679-1688	digestive	abstract[108]|object[109]	new[108]|new[109]	_	_
16-13	1689-1694	tract	abstract[108]|object[109]	new[108]|new[109]	_	_
16-14	1695-1696	,	_	_	_	_
16-15	1697-1708	hemorrhagic	event[110]	giv[110]	_	_
16-16	1709-1721	inflammation	event[110]	giv[110]	_	_
16-17	1722-1723	,	_	_	_	_
16-18	1724-1727	and	_	_	_	_
16-19	1728-1737	dystrophy	abstract[111]	new[111]	_	_
16-20	1738-1740	in	abstract[111]	new[111]	_	_
16-21	1741-1744	the	abstract[111]|object[112]	new[111]|new[112]	_	_
16-22	1745-1750	brain	abstract[111]|object[112]	new[111]|new[112]	_	_
16-23	1751-1752	,	abstract[111]	new[111]	_	_
16-24	1753-1758	heart	abstract[111]|object	new[111]|new	_	_
16-25	1759-1760	,	abstract[111]	new[111]	_	_
16-26	1761-1767	kidney	abstract[111]|object	new[111]|new	_	_
16-27	1768-1769	,	abstract[111]	new[111]	_	_
16-28	1770-1773	and	abstract[111]	new[111]	_	_
16-29	1774-1779	liver	abstract[111]|object	new[111]|new	coref	21-27[146_0]
16-30	1780-1781	.	_	_	_	_

#Text=The walls of blood vessels are damaged , provoking hemorrhagic diathesis .
17-1	1782-1785	The	object[116]	new[116]	_	_
17-2	1786-1791	walls	object[116]	new[116]	_	_
17-3	1792-1794	of	object[116]	new[116]	_	_
17-4	1795-1800	blood	object[116]|substance|object[118]	new[116]|new|new[118]	_	_
17-5	1801-1808	vessels	object[116]|object[118]	new[116]|new[118]	_	_
17-6	1809-1812	are	_	_	_	_
17-7	1813-1820	damaged	_	_	_	_
17-8	1821-1822	,	_	_	_	_
17-9	1823-1832	provoking	_	_	_	_
17-10	1833-1844	hemorrhagic	abstract[119]	new[119]	_	_
17-11	1845-1854	diathesis	abstract[119]	new[119]	_	_
17-12	1855-1856	.	_	_	_	_

#Text=T-2 also affects animals , with monogastric animals being more susceptible than ruminants .
18-1	1857-1860	T-2	substance	giv	ana	19-1
18-2	1861-1865	also	_	_	_	_
18-3	1866-1873	affects	_	_	_	_
18-4	1874-1881	animals	animal	new	coref	18-7[122_0]
18-5	1882-1883	,	_	_	_	_
18-6	1884-1888	with	_	_	_	_
18-7	1889-1900	monogastric	animal[122]	giv[122]	coref	21-21[0_122]
18-8	1901-1908	animals	animal[122]	giv[122]	_	_
18-9	1909-1914	being	_	_	_	_
18-10	1915-1919	more	_	_	_	_
18-11	1920-1931	susceptible	_	_	_	_
18-12	1932-1936	than	_	_	_	_
18-13	1937-1946	ruminants	animal	new	coref	19-4[125_0]
18-14	1947-1948	.	_	_	_	_

#Text=This is because ruminants , such as cattle , possess a rumen where de-acetylation and de-epoxidation of the toxin take place , thus limiting its toxicity .
19-1	1949-1953	This	substance	giv	ana	19-25
19-2	1954-1956	is	_	_	_	_
19-3	1957-1964	because	_	_	_	_
19-4	1965-1974	ruminants	animal[125]	giv[125]	_	_
19-5	1975-1976	,	animal[125]	giv[125]	_	_
19-6	1977-1981	such	animal[125]	giv[125]	_	_
19-7	1982-1984	as	animal[125]	giv[125]	_	_
19-8	1985-1991	cattle	animal[125]|animal	giv[125]|new	_	_
19-9	1992-1993	,	_	_	_	_
19-10	1994-2001	possess	_	_	_	_
19-11	2002-2003	a	substance[127]	new[127]	_	_
19-12	2004-2009	rumen	substance[127]	new[127]	_	_
19-13	2010-2015	where	substance[127]	new[127]	_	_
19-14	2016-2030	de-acetylation	substance[127]|abstract	new[127]|new	_	_
19-15	2031-2034	and	substance[127]	new[127]	_	_
19-16	2035-2049	de-epoxidation	substance[127]|event[129]	new[127]|new[129]	_	_
19-17	2050-2052	of	substance[127]|event[129]	new[127]|new[129]	_	_
19-18	2053-2056	the	substance[127]|event[129]|substance[130]	new[127]|new[129]|giv[130]	coref	20-1[133_130]
19-19	2057-2062	toxin	substance[127]|event[129]|substance[130]	new[127]|new[129]|giv[130]	_	_
19-20	2063-2067	take	substance[127]	new[127]	_	_
19-21	2068-2073	place	substance[127]	new[127]	_	_
19-22	2074-2075	,	_	_	_	_
19-23	2076-2080	thus	_	_	_	_
19-24	2081-2089	limiting	_	_	_	_
19-25	2090-2093	its	substance|abstract[132]	giv|giv[132]	coref|coref	21-5|34-25[259_132]
19-26	2094-2102	toxicity	abstract[132]	giv[132]	_	_
19-27	2103-2104	.	_	_	_	_

#Text=The toxin also affects poultry , causing ulcerative and necrotic lesions as well as oral lesions , thereby leading to refusal of feed .
20-1	2105-2108	The	substance[133]	giv[133]	coref	21-5[141_133]
20-2	2109-2114	toxin	substance[133]	giv[133]	_	_
20-3	2115-2119	also	_	_	_	_
20-4	2120-2127	affects	_	_	_	_
20-5	2128-2135	poultry	animal	new	_	_
20-6	2136-2137	,	_	_	_	_
20-7	2138-2145	causing	_	_	_	_
20-8	2146-2156	ulcerative	object[135]	new[135]	_	_
20-9	2157-2160	and	object[135]	new[135]	_	_
20-10	2161-2169	necrotic	object[135]	new[135]	_	_
20-11	2170-2177	lesions	object[135]	new[135]	_	_
20-12	2178-2180	as	_	_	_	_
20-13	2181-2185	well	_	_	_	_
20-14	2186-2188	as	_	_	_	_
20-15	2189-2193	oral	object[136]	new[136]	_	_
20-16	2194-2201	lesions	object[136]	new[136]	_	_
20-17	2202-2203	,	_	_	_	_
20-18	2204-2211	thereby	_	_	_	_
20-19	2212-2219	leading	_	_	_	_
20-20	2220-2222	to	_	_	_	_
20-21	2223-2230	refusal	event[137]	new[137]	_	_
20-22	2231-2233	of	event[137]	new[137]	_	_
20-23	2234-2238	feed	event[137]|substance	new[137]|new	coref	30-8[225_0]
20-24	2239-2240	.	_	_	_	_

#Text=Studies have revealed that T-2 toxin is easily absorbed in the intestinal tract and is toxic to the organs of animals affecting the digestive system and liver of animals .
21-1	2241-2248	Studies	abstract	new	coref	40-19[298_0]
21-2	2249-2253	have	_	_	_	_
21-3	2254-2262	revealed	_	_	_	_
21-4	2263-2267	that	_	_	_	_
21-5	2268-2271	T-2	substance|substance[141]	giv|giv[141]	coref|coref	34-28|34-28[261_141]
21-6	2272-2277	toxin	substance[141]	giv[141]	_	_
21-7	2278-2280	is	_	_	_	_
21-8	2281-2287	easily	_	_	_	_
21-9	2288-2296	absorbed	_	_	_	_
21-10	2297-2299	in	_	_	_	_
21-11	2300-2303	the	object[142]	giv[142]	_	_
21-12	2304-2314	intestinal	object[142]	giv[142]	_	_
21-13	2315-2320	tract	object[142]	giv[142]	_	_
21-14	2321-2324	and	_	_	_	_
21-15	2325-2327	is	_	_	_	_
21-16	2328-2333	toxic	_	_	_	_
21-17	2334-2336	to	_	_	_	_
21-18	2337-2340	the	object[143]	new[143]	_	_
21-19	2341-2347	organs	object[143]	new[143]	_	_
21-20	2348-2350	of	object[143]	new[143]	_	_
21-21	2351-2358	animals	object[143]|animal	new[143]|giv	coref	21-29
21-22	2359-2368	affecting	_	_	_	_
21-23	2369-2372	the	abstract[145]	giv[145]	_	_
21-24	2373-2382	digestive	abstract[145]	giv[145]	_	_
21-25	2383-2389	system	abstract[145]	giv[145]	_	_
21-26	2390-2393	and	_	_	_	_
21-27	2394-2399	liver	object[146]	giv[146]	_	_
21-28	2400-2402	of	object[146]	giv[146]	_	_
21-29	2403-2410	animals	object[146]|animal	giv[146]|giv	_	_
21-30	2411-2412	.	_	_	_	_

#Text=Decontamination processes involving physical , biological , and chemical methods are frequently required for the removal , destruction , and decontamination of mycotoxins .
22-1	2413-2428	Decontamination	abstract|abstract[149]	new|new[149]	_	_
22-2	2429-2438	processes	abstract[149]	new[149]	_	_
22-3	2439-2448	involving	abstract[149]	new[149]	_	_
22-4	2449-2457	physical	abstract[149]|abstract[150]	new[149]|new[150]	coref	25-7[177_150]
22-5	2458-2459	,	abstract[149]|abstract[150]	new[149]|new[150]	_	_
22-6	2460-2470	biological	abstract[149]|abstract[150]	new[149]|new[150]	_	_
22-7	2471-2472	,	abstract[149]|abstract[150]	new[149]|new[150]	_	_
22-8	2473-2476	and	abstract[149]|abstract[150]	new[149]|new[150]	_	_
22-9	2477-2485	chemical	abstract[149]|abstract[150]	new[149]|new[150]	_	_
22-10	2486-2493	methods	abstract[149]|abstract[150]	new[149]|new[150]	_	_
22-11	2494-2497	are	_	_	_	_
22-12	2498-2508	frequently	_	_	_	_
22-13	2509-2517	required	_	_	_	_
22-14	2518-2521	for	_	_	_	_
22-15	2522-2525	the	event[151]	new[151]	_	_
22-16	2526-2533	removal	event[151]	new[151]	_	_
22-17	2534-2535	,	_	_	_	_
22-18	2536-2547	destruction	event	new	_	_
22-19	2548-2549	,	_	_	_	_
22-20	2550-2553	and	_	_	_	_
22-21	2554-2569	decontamination	event[153]	new[153]	coref	26-19[186_153]
22-22	2570-2572	of	event[153]	new[153]	_	_
22-23	2573-2583	mycotoxins	event[153]|substance	new[153]|giv	coref	23-20[163_0]
22-24	2584-2585	.	_	_	_	_

#Text=Biological approaches include the activity of microorganisms ( algae , bacteria , filamentous fungi , and yeasts ) against mycotoxins using antibiosis or competition for nutrients and space .
23-1	2586-2596	Biological	abstract[155]	new[155]	coref	24-1[168_155]
23-2	2597-2607	approaches	abstract[155]	new[155]	_	_
23-3	2608-2615	include	_	_	_	_
23-4	2616-2619	the	event[156]	new[156]	_	_
23-5	2620-2628	activity	event[156]	new[156]	_	_
23-6	2629-2631	of	event[156]	new[156]	_	_
23-7	2632-2646	microorganisms	event[156]|plant	new[156]|new	appos	23-9
23-8	2647-2648	(	_	_	_	_
23-9	2649-2654	algae	plant|plant[159]	giv|giv[159]	appos|appos	23-9[159_0]|23-13[161_159]
23-10	2655-2656	,	plant[159]	giv[159]	_	_
23-11	2657-2665	bacteria	plant[159]|animal	giv[159]|new	_	_
23-12	2666-2667	,	plant[159]	giv[159]	_	_
23-13	2668-2679	filamentous	plant[159]|plant[161]	giv[159]|giv[161]	appos	23-17[0_161]
23-14	2680-2685	fungi	plant[159]|plant[161]	giv[159]|giv[161]	_	_
23-15	2686-2687	,	plant[159]	giv[159]	_	_
23-16	2688-2691	and	plant[159]	giv[159]	_	_
23-17	2692-2698	yeasts	plant[159]|plant	giv[159]|giv	_	_
23-18	2699-2700	)	_	_	_	_
23-19	2701-2708	against	_	_	_	_
23-20	2709-2719	mycotoxins	substance[163]	giv[163]	coref	24-6[0_163]
23-21	2720-2725	using	substance[163]	giv[163]	_	_
23-22	2726-2736	antibiosis	substance[163]|substance	giv[163]|new	_	_
23-23	2737-2739	or	substance[163]	giv[163]	_	_
23-24	2740-2751	competition	substance[163]|abstract[165]	giv[163]|new[165]	_	_
23-25	2752-2755	for	substance[163]|abstract[165]	giv[163]|new[165]	_	_
23-26	2756-2765	nutrients	substance[163]|abstract[165]|substance	giv[163]|new[165]|new	_	_
23-27	2766-2769	and	substance[163]|abstract[165]	giv[163]|new[165]	_	_
23-28	2770-2775	space	substance[163]|abstract[165]|place	giv[163]|new[165]|new	_	_
23-29	2776-2777	.	_	_	_	_

#Text=Chemical approaches help to degrade mycotoxins by various gases , aldehydes , oxidizing agents , acids , and bases .
24-1	2778-2786	Chemical	abstract[168]	giv[168]	_	_
24-2	2787-2797	approaches	abstract[168]	giv[168]	_	_
24-3	2798-2802	help	_	_	_	_
24-4	2803-2805	to	_	_	_	_
24-5	2806-2813	degrade	_	_	_	_
24-6	2814-2824	mycotoxins	substance	giv	coref	25-14
24-7	2825-2827	by	_	_	_	_
24-8	2828-2835	various	substance[170]	new[170]	_	_
24-9	2836-2841	gases	substance[170]	new[170]	_	_
24-10	2842-2843	,	_	_	_	_
24-11	2844-2853	aldehydes	substance	new	_	_
24-12	2854-2855	,	_	_	_	_
24-13	2856-2865	oxidizing	person[172]	new[172]	coref	30-5[223_172]
24-14	2866-2872	agents	person[172]	new[172]	_	_
24-15	2873-2874	,	_	_	_	_
24-16	2875-2880	acids	substance	new	_	_
24-17	2881-2882	,	_	_	_	_
24-18	2883-2886	and	_	_	_	_
24-19	2887-2892	bases	abstract	new	_	_
24-20	2893-2894	.	_	_	_	_

#Text=The EC supports the application of physical methods and sorting procedures for decontaminating mycotoxins .
25-1	2895-2898	The	organization[175]	new[175]	_	_
25-2	2899-2901	EC	organization[175]	new[175]	_	_
25-3	2902-2910	supports	_	_	_	_
25-4	2911-2914	the	abstract[176]	new[176]	_	_
25-5	2915-2926	application	abstract[176]	new[176]	_	_
25-6	2927-2929	of	abstract[176]	new[176]	_	_
25-7	2930-2938	physical	abstract[176]|abstract[177]|abstract[178]	new[176]|giv[177]|giv[178]	coref	25-7[178_177]
25-8	2939-2946	methods	abstract[176]|abstract[177]|abstract[178]	new[176]|giv[177]|giv[178]	_	_
25-9	2947-2950	and	abstract[176]|abstract[178]	new[176]|giv[178]	_	_
25-10	2951-2958	sorting	abstract[176]|abstract[178]|abstract[179]	new[176]|giv[178]|new[179]	_	_
25-11	2959-2969	procedures	abstract[176]|abstract[178]|abstract[179]	new[176]|giv[178]|new[179]	_	_
25-12	2970-2973	for	_	_	_	_
25-13	2974-2989	decontaminating	_	_	_	_
25-14	2990-3000	mycotoxins	substance	giv	coref	26-10
25-15	3001-3002	.	_	_	_	_

#Text=However , neither the mixing of batches to reduce mycotoxins to levels below the maximum tolerable limits nor decontamination using chemicals is permitted by the European Union .
26-1	3003-3010	However	_	_	_	_
26-2	3011-3012	,	_	_	_	_
26-3	3013-3020	neither	event[181]	new[181]	_	_
26-4	3021-3024	the	event[181]	new[181]	_	_
26-5	3025-3031	mixing	event[181]	new[181]	_	_
26-6	3032-3034	of	event[181]	new[181]	_	_
26-7	3035-3042	batches	event[181]|abstract[182]	new[181]|new[182]	_	_
26-8	3043-3045	to	event[181]|abstract[182]	new[181]|new[182]	_	_
26-9	3046-3052	reduce	event[181]|abstract[182]	new[181]|new[182]	_	_
26-10	3053-3063	mycotoxins	event[181]|abstract[182]|substance	new[181]|new[182]|giv	coref	31-16[236_0]
26-11	3064-3066	to	event[181]|abstract[182]	new[181]|new[182]	_	_
26-12	3067-3073	levels	event[181]|abstract[182]|abstract[184]	new[181]|new[182]|new[184]	_	_
26-13	3074-3079	below	event[181]|abstract[182]|abstract[184]	new[181]|new[182]|new[184]	_	_
26-14	3080-3083	the	event[181]|abstract[182]|abstract[184]|abstract[185]	new[181]|new[182]|new[184]|new[185]	_	_
26-15	3084-3091	maximum	event[181]|abstract[182]|abstract[184]|abstract[185]	new[181]|new[182]|new[184]|new[185]	_	_
26-16	3092-3101	tolerable	event[181]|abstract[182]|abstract[184]|abstract[185]	new[181]|new[182]|new[184]|new[185]	_	_
26-17	3102-3108	limits	event[181]|abstract[182]|abstract[184]|abstract[185]	new[181]|new[182]|new[184]|new[185]	_	_
26-18	3109-3112	nor	_	_	_	_
26-19	3113-3128	decontamination	event[186]	giv[186]	coref	29-24[0_186]
26-20	3129-3134	using	event[186]	giv[186]	_	_
26-21	3135-3144	chemicals	event[186]|substance	giv[186]|new	_	_
26-22	3145-3147	is	_	_	_	_
26-23	3148-3157	permitted	_	_	_	_
26-24	3158-3160	by	_	_	_	_
26-25	3161-3164	the	organization[188]	new[188]	_	_
26-26	3165-3173	European	organization[188]	new[188]	_	_
26-27	3174-3179	Union	organization[188]	new[188]	_	_
26-28	3180-3181	.	_	_	_	_

#Text=Physical methods of detoxification include irradiation ( gamma or ultraviolet irradiation ) , solvent extraction , inactivation by heat , and the use of mineral adsorbents ( mainly clays ) .
27-1	3182-3190	Physical	abstract[189]	new[189]	coref	29-18[217_189]
27-2	3191-3198	methods	abstract[189]	new[189]	_	_
27-3	3199-3201	of	abstract[189]	new[189]	_	_
27-4	3202-3216	detoxification	abstract[189]|abstract	new[189]|new	_	_
27-5	3217-3224	include	_	_	_	_
27-6	3225-3236	irradiation	abstract	new	appos	27-8[193_0]
27-7	3237-3238	(	_	_	_	_
27-8	3239-3244	gamma	abstract[193]	giv[193]	coref	28-4[203_193]
27-9	3245-3247	or	abstract[193]	giv[193]	_	_
27-10	3248-3259	ultraviolet	object|abstract[193]	new|giv[193]	_	_
27-11	3260-3271	irradiation	abstract[193]	giv[193]	_	_
27-12	3272-3273	)	_	_	_	_
27-13	3274-3275	,	_	_	_	_
27-14	3276-3283	solvent	substance|event[195]	new|new[195]	_	_
27-15	3284-3294	extraction	event[195]	new[195]	_	_
27-16	3295-3296	,	_	_	_	_
27-17	3297-3309	inactivation	event[196]	new[196]	coref	28-20[208_196]
27-18	3310-3312	by	event[196]	new[196]	_	_
27-19	3313-3317	heat	event[196]|substance	new[196]|new	coref	28-22
27-20	3318-3319	,	_	_	_	_
27-21	3320-3323	and	_	_	_	_
27-22	3324-3327	the	event[198]	new[198]	_	_
27-23	3328-3331	use	event[198]	new[198]	_	_
27-24	3332-3334	of	event[198]	new[198]	_	_
27-25	3335-3342	mineral	event[198]|abstract[199]	new[198]|new[199]	coref	29-4[214_199]
27-26	3343-3353	adsorbents	event[198]|abstract[199]	new[198]|new[199]	_	_
27-27	3354-3355	(	_	_	_	_
27-28	3356-3362	mainly	substance[200]	new[200]	_	_
27-29	3363-3368	clays	substance[200]	new[200]	_	_
27-30	3369-3370	)	_	_	_	_
27-31	3371-3372	.	_	_	_	_

#Text=The disadvantages of food irradiation are the high costs involved and loss of vitamins ( avitaminosis ) , while inactivation by heat may lead to a loss in nutritional properties of the commodities .
28-1	3373-3376	The	abstract[201]	new[201]	coref	28-7[204_201]
28-2	3377-3390	disadvantages	abstract[201]	new[201]	_	_
28-3	3391-3393	of	abstract[201]	new[201]	_	_
28-4	3394-3398	food	abstract[201]|substance|abstract[203]	new[201]|new|giv[203]	_	_
28-5	3399-3410	irradiation	abstract[201]|abstract[203]	new[201]|giv[203]	_	_
28-6	3411-3414	are	_	_	_	_
28-7	3415-3418	the	abstract[204]	giv[204]	_	_
28-8	3419-3423	high	abstract[204]	giv[204]	_	_
28-9	3424-3429	costs	abstract[204]	giv[204]	_	_
28-10	3430-3438	involved	abstract[204]	giv[204]	_	_
28-11	3439-3442	and	abstract[204]	giv[204]	_	_
28-12	3443-3447	loss	abstract[204]|event[205]	giv[204]|new[205]	coref	28-26[210_205]
28-13	3448-3450	of	abstract[204]|event[205]	giv[204]|new[205]	_	_
28-14	3451-3459	vitamins	abstract[204]|event[205]|substance	giv[204]|new[205]|new	_	_
28-15	3460-3461	(	_	_	_	_
28-16	3462-3474	avitaminosis	abstract	new	_	_
28-17	3475-3476	)	_	_	_	_
28-18	3477-3478	,	_	_	_	_
28-19	3479-3484	while	_	_	_	_
28-20	3485-3497	inactivation	event[208]	giv[208]	_	_
28-21	3498-3500	by	event[208]	giv[208]	_	_
28-22	3501-3505	heat	event[208]|substance	giv[208]|giv	_	_
28-23	3506-3509	may	_	_	_	_
28-24	3510-3514	lead	_	_	_	_
28-25	3515-3517	to	_	_	_	_
28-26	3518-3519	a	event[210]	giv[210]	_	_
28-27	3520-3524	loss	event[210]	giv[210]	_	_
28-28	3525-3527	in	event[210]	giv[210]	_	_
28-29	3528-3539	nutritional	event[210]|abstract[211]	giv[210]|new[211]	coref	29-22[221_211]
28-30	3540-3550	properties	event[210]|abstract[211]	giv[210]|new[211]	_	_
28-31	3551-3553	of	event[210]|abstract[211]	giv[210]|new[211]	_	_
28-32	3554-3557	the	event[210]|abstract[211]|substance[212]	giv[210]|new[211]|new[212]	ana	29-22[0_212]
28-33	3558-3569	commodities	event[210]|abstract[211]|substance[212]	giv[210]|new[211]|new[212]	_	_
28-34	3570-3571	.	_	_	_	_

#Text=The use of mineral adsorbents , such as clay , is a cheaper and safer alternative to these methods , revealing their mycotoxin decontamination properties .
29-1	3572-3575	The	abstract[213]	new[213]	coref	29-12[216_213]
29-2	3576-3579	use	abstract[213]	new[213]	_	_
29-3	3580-3582	of	abstract[213]	new[213]	_	_
29-4	3583-3590	mineral	abstract[213]|abstract[214]	new[213]|giv[214]	_	_
29-5	3591-3601	adsorbents	abstract[213]|abstract[214]	new[213]|giv[214]	_	_
29-6	3602-3603	,	abstract[213]|abstract[214]	new[213]|giv[214]	_	_
29-7	3604-3608	such	abstract[213]|abstract[214]	new[213]|giv[214]	_	_
29-8	3609-3611	as	abstract[213]|abstract[214]	new[213]|giv[214]	_	_
29-9	3612-3616	clay	abstract[213]|abstract[214]|substance	new[213]|giv[214]|new	coref	32-1[240_0]
29-10	3617-3618	,	_	_	_	_
29-11	3619-3621	is	_	_	_	_
29-12	3622-3623	a	abstract[216]	giv[216]	coref	32-15[245_216]
29-13	3624-3631	cheaper	abstract[216]	giv[216]	_	_
29-14	3632-3635	and	abstract[216]	giv[216]	_	_
29-15	3636-3641	safer	abstract[216]	giv[216]	_	_
29-16	3642-3653	alternative	abstract[216]	giv[216]	_	_
29-17	3654-3656	to	abstract[216]	giv[216]	_	_
29-18	3657-3662	these	abstract[216]|abstract[217]	giv[216]|giv[217]	_	_
29-19	3663-3670	methods	abstract[216]|abstract[217]	giv[216]|giv[217]	_	_
29-20	3671-3672	,	abstract[216]	giv[216]	_	_
29-21	3673-3682	revealing	abstract[216]	giv[216]	_	_
29-22	3683-3688	their	abstract[216]|substance|abstract[221]	giv[216]|giv|giv[221]	_	_
29-23	3689-3698	mycotoxin	abstract[216]|animal|abstract[221]	giv[216]|new|giv[221]	coref	30-18
29-24	3699-3714	decontamination	abstract[216]|event|abstract[221]	giv[216]|giv|giv[221]	coref	35-16
29-25	3715-3725	properties	abstract[216]|abstract[221]	giv[216]|giv[221]	_	_
29-26	3726-3727	.	_	_	_	_

#Text=Clays also serve as anti-caking agents in animal feed , and they are highly regarded as effective mycotoxin binding agents in animal feeds by enterosorption .
30-1	3728-3733	Clays	person	new	_	_
30-2	3734-3738	also	_	_	_	_
30-3	3739-3744	serve	_	_	_	_
30-4	3745-3747	as	_	_	_	_
30-5	3748-3759	anti-caking	person[223]	giv[223]	ana	30-12[0_223]
30-6	3760-3766	agents	person[223]	giv[223]	_	_
30-7	3767-3769	in	_	_	_	_
30-8	3770-3776	animal	animal|substance[225]	new|giv[225]	coref|coref	30-22|31-18[238_225]
30-9	3777-3781	feed	substance[225]	giv[225]	_	_
30-10	3782-3783	,	_	_	_	_
30-11	3784-3787	and	_	_	_	_
30-12	3788-3792	they	person	giv	coref	30-17[228_0]
30-13	3793-3796	are	_	_	_	_
30-14	3797-3803	highly	_	_	_	_
30-15	3804-3812	regarded	_	_	_	_
30-16	3813-3815	as	_	_	_	_
30-17	3816-3825	effective	person[228]	giv[228]	_	_
30-18	3826-3835	mycotoxin	animal|person[228]	giv|giv[228]	coref	35-15
30-19	3836-3843	binding	person[228]	giv[228]	_	_
30-20	3844-3850	agents	person[228]	giv[228]	_	_
30-21	3851-3853	in	person[228]	giv[228]	_	_
30-22	3854-3860	animal	person[228]|animal|substance[230]	giv[228]|giv|new[230]	coref	31-18
30-23	3861-3866	feeds	person[228]|substance[230]	giv[228]|new[230]	_	_
30-24	3867-3869	by	_	_	_	_
30-25	3870-3884	enterosorption	substance	new	_	_
30-26	3885-3886	.	_	_	_	_

#Text=Enzymes such as oxidoreductases and hydrolases have also been thoroughly explored in the mitigation of mycotoxins in animal feed .
31-1	3887-3894	Enzymes	abstract[232]	new[232]	_	_
31-2	3895-3899	such	abstract[232]	new[232]	_	_
31-3	3900-3902	as	abstract[232]	new[232]	_	_
31-4	3903-3918	oxidoreductases	abstract[232]|abstract	new[232]|new	_	_
31-5	3919-3922	and	abstract[232]	new[232]	_	_
31-6	3923-3933	hydrolases	abstract[232]|abstract	new[232]|new	_	_
31-7	3934-3938	have	_	_	_	_
31-8	3939-3943	also	_	_	_	_
31-9	3944-3948	been	_	_	_	_
31-10	3949-3959	thoroughly	_	_	_	_
31-11	3960-3968	explored	_	_	_	_
31-12	3969-3971	in	_	_	_	_
31-13	3972-3975	the	abstract[235]	new[235]	_	_
31-14	3976-3986	mitigation	abstract[235]	new[235]	_	_
31-15	3987-3989	of	abstract[235]	new[235]	_	_
31-16	3990-4000	mycotoxins	abstract[235]|substance[236]	new[235]|giv[236]	_	_
31-17	4001-4003	in	abstract[235]|substance[236]	new[235]|giv[236]	_	_
31-18	4004-4010	animal	abstract[235]|substance[236]|animal|substance[238]	new[235]|giv[236]|giv|giv[238]	_	_
31-19	4011-4015	feed	abstract[235]|substance[236]|substance[238]	new[235]|giv[236]|giv[238]	_	_
31-20	4016-4017	.	_	_	_	_

#Text=Montmorillonite clay has pharmaceutical applications where it serves as an excipient in drugs for oral or topical use .
32-1	4018-4033	Montmorillonite	place|substance[240]	new|giv[240]	ana|coref	32-7[0_240]|33-4
32-2	4034-4038	clay	substance[240]	giv[240]	_	_
32-3	4039-4042	has	_	_	_	_
32-4	4043-4057	pharmaceutical	abstract[241]	new[241]	_	_
32-5	4058-4070	applications	abstract[241]	new[241]	_	_
32-6	4071-4076	where	abstract[241]	new[241]	_	_
32-7	4077-4079	it	abstract[241]|substance	new[241]|giv	coref	33-4[248_0]
32-8	4080-4086	serves	abstract[241]	new[241]	_	_
32-9	4087-4089	as	abstract[241]	new[241]	_	_
32-10	4090-4092	an	abstract[241]|person[243]	new[241]|new[243]	_	_
32-11	4093-4102	excipient	abstract[241]|person[243]	new[241]|new[243]	_	_
32-12	4103-4105	in	abstract[241]|person[243]	new[241]|new[243]	_	_
32-13	4106-4111	drugs	abstract[241]|person[243]|substance[244]	new[241]|new[243]|new[244]	_	_
32-14	4112-4115	for	abstract[241]|person[243]|substance[244]	new[241]|new[243]|new[244]	_	_
32-15	4116-4120	oral	abstract[241]|person[243]|substance[244]|abstract[245]	new[241]|new[243]|new[244]|giv[245]	_	_
32-16	4121-4123	or	abstract[241]|person[243]|substance[244]|abstract[245]	new[241]|new[243]|new[244]|giv[245]	_	_
32-17	4124-4131	topical	abstract[241]|person[243]|substance[244]|abstract[245]	new[241]|new[243]|new[244]|giv[245]	_	_
32-18	4132-4135	use	abstract[241]|person[243]|substance[244]|abstract[245]	new[241]|new[243]|new[244]|giv[245]	_	_
32-19	4136-4137	.	_	_	_	_

#Text=The cytotoxicity of montmorillonite clay is low both in vitro and in vivo .
33-1	4138-4141	The	substance[246]	new[246]	_	_
33-2	4142-4154	cytotoxicity	substance[246]	new[246]	_	_
33-3	4155-4157	of	substance[246]	new[246]	_	_
33-4	4158-4173	montmorillonite	substance[246]|place|substance[248]	new[246]|giv|giv[248]	coref|coref	35-3[0_248]|36-1
33-5	4174-4178	clay	substance[246]|substance[248]	new[246]|giv[248]	_	_
33-6	4179-4181	is	_	_	_	_
33-7	4182-4185	low	_	_	_	_
33-8	4186-4190	both	organization[249]	new[249]	_	_
33-9	4191-4193	in	organization[249]	new[249]	_	_
33-10	4194-4199	vitro	organization[249]	new[249]	_	_
33-11	4200-4203	and	_	_	_	_
33-12	4204-4206	in	_	_	_	_
33-13	4207-4211	vivo	abstract	new	coref	34-22
33-14	4212-4213	.	_	_	_	_

#Text=A study by Wei et al. showed that modified hydrated sodium calcium aluminosilicate ( HSCAS ) adsorbent could be used in vivo to reduce toxicity induced by T-2 toxin .
34-1	4214-4215	A	abstract[251]	new[251]	_	_
34-2	4216-4221	study	abstract[251]	new[251]	_	_
34-3	4222-4224	by	abstract[251]	new[251]	_	_
34-4	4225-4228	Wei	abstract[251]|person	new[251]|new	_	_
34-5	4229-4231	et	abstract[251]	new[251]	_	_
34-6	4232-4235	al.	abstract[251]	new[251]	_	_
34-7	4236-4242	showed	_	_	_	_
34-8	4243-4247	that	_	_	_	_
34-9	4248-4256	modified	substance[255]|substance[257]	new[255]|new[257]	appos	34-15[0_255]
34-10	4257-4265	hydrated	substance[255]|substance[257]	new[255]|new[257]	_	_
34-11	4266-4272	sodium	substance|substance[255]|substance[257]	new|new[255]|new[257]	_	_
34-12	4273-4280	calcium	substance|substance[255]|substance[257]	new|new[255]|new[257]	_	_
34-13	4281-4296	aluminosilicate	substance[255]|substance[257]	new[255]|new[257]	_	_
34-14	4297-4298	(	substance[257]	new[257]	_	_
34-15	4299-4304	HSCAS	substance|substance[257]	giv|new[257]	_	_
34-16	4305-4306	)	substance[257]	new[257]	_	_
34-17	4307-4316	adsorbent	substance[257]	new[257]	_	_
34-18	4317-4322	could	_	_	_	_
34-19	4323-4325	be	_	_	_	_
34-20	4326-4330	used	_	_	_	_
34-21	4331-4333	in	_	_	_	_
34-22	4334-4338	vivo	abstract	giv	_	_
34-23	4339-4341	to	_	_	_	_
34-24	4342-4348	reduce	_	_	_	_
34-25	4349-4357	toxicity	abstract[259]	giv[259]	_	_
34-26	4358-4365	induced	abstract[259]	giv[259]	_	_
34-27	4366-4368	by	abstract[259]	giv[259]	_	_
34-28	4369-4372	T-2	abstract[259]|substance|substance[261]	giv[259]|giv|giv[261]	_	_
34-29	4373-4378	toxin	abstract[259]|substance[261]	giv[259]|giv[261]	_	_
34-30	4379-4380	.	_	_	_	_

#Text=Therefore , clay can be safely expended in the storage of cereal crops for mycotoxin decontamination purposes .
35-1	4381-4390	Therefore	_	_	_	_
35-2	4391-4392	,	_	_	_	_
35-3	4393-4397	clay	substance	giv	coref	40-3
35-4	4398-4401	can	_	_	_	_
35-5	4402-4404	be	_	_	_	_
35-6	4405-4411	safely	_	_	_	_
35-7	4412-4420	expended	_	_	_	_
35-8	4421-4423	in	_	_	_	_
35-9	4424-4427	the	substance[263]	new[263]	_	_
35-10	4428-4435	storage	substance[263]	new[263]	_	_
35-11	4436-4438	of	substance[263]	new[263]	_	_
35-12	4439-4445	cereal	substance[263]|substance|plant[265]	new[263]|new|new[265]	_	_
35-13	4446-4451	crops	substance[263]|plant[265]	new[263]|new[265]	_	_
35-14	4452-4455	for	_	_	_	_
35-15	4456-4465	mycotoxin	animal|abstract[268]	giv|new[268]	_	_
35-16	4466-4481	decontamination	event|abstract[268]	giv|new[268]	_	_
35-17	4482-4490	purposes	abstract[268]	new[268]	_	_
35-18	4491-4492	.	_	_	_	_

#Text=Montmorillonite , when compared with other nanoclays , has an advantage because it is abundant and environmentally friendly .
36-1	4493-4508	Montmorillonite	place	giv	coref	37-4
36-2	4509-4510	,	_	_	_	_
36-3	4511-4515	when	_	_	_	_
36-4	4516-4524	compared	_	_	_	_
36-5	4525-4529	with	_	_	_	_
36-6	4530-4535	other	object[270]	new[270]	_	_
36-7	4536-4545	nanoclays	object[270]	new[270]	_	_
36-8	4546-4547	,	_	_	_	_
36-9	4548-4551	has	_	_	_	_
36-10	4552-4554	an	abstract[271]	new[271]	ana	36-13[0_271]
36-11	4555-4564	advantage	abstract[271]	new[271]	_	_
36-12	4565-4572	because	_	_	_	_
36-13	4573-4575	it	abstract	giv	_	_
36-14	4576-4578	is	_	_	_	_
36-15	4579-4587	abundant	_	_	_	_
36-16	4588-4591	and	_	_	_	_
36-17	4592-4607	environmentally	_	_	_	_
36-18	4608-4616	friendly	_	_	_	_
36-19	4617-4618	.	_	_	_	_

#Text=Each layer of montmorillonite has a lateral dimension of 200 – 600 nm .
37-1	4619-4623	Each	substance[273]	new[273]	_	_
37-2	4624-4629	layer	substance[273]	new[273]	_	_
37-3	4630-4632	of	substance[273]	new[273]	_	_
37-4	4633-4648	montmorillonite	substance[273]|place	new[273]|giv	ana	38-1
37-5	4649-4652	has	_	_	_	_
37-6	4653-4654	a	abstract[275]	new[275]	_	_
37-7	4655-4662	lateral	abstract[275]	new[275]	_	_
37-8	4663-4672	dimension	abstract[275]	new[275]	_	_
37-9	4673-4675	of	abstract[275]	new[275]	_	_
37-10	4676-4679	200	abstract[275]|abstract[276]	new[275]|new[276]	_	_
37-11	4680-4681	–	abstract[275]|abstract[276]	new[275]|new[276]	_	_
37-12	4682-4685	600	abstract[275]|abstract[276]	new[275]|new[276]	_	_
37-13	4686-4688	nm	abstract[275]|abstract[276]	new[275]|new[276]	_	_
37-14	4689-4690	.	_	_	_	_

#Text=It is made up of an octahedral sheet sandwiched between two tetrahedral sheets .
38-1	4691-4693	It	place	giv	coref	40-14
38-2	4694-4696	is	_	_	_	_
38-3	4697-4701	made	_	_	_	_
38-4	4702-4704	up	_	_	_	_
38-5	4705-4707	of	_	_	_	_
38-6	4708-4710	an	object[278]	new[278]	_	_
38-7	4711-4721	octahedral	object[278]	new[278]	_	_
38-8	4722-4727	sheet	object[278]	new[278]	_	_
38-9	4728-4738	sandwiched	object[278]	new[278]	_	_
38-10	4739-4746	between	object[278]	new[278]	_	_
38-11	4747-4750	two	object[278]|object[279]	new[278]|new[279]	coref	39-4[281_279]
38-12	4751-4762	tetrahedral	object[278]|object[279]	new[278]|new[279]	_	_
38-13	4763-4769	sheets	object[278]|object[279]	new[278]|new[279]	_	_
38-14	4770-4771	.	_	_	_	_

#Text=The arrangement of the sheets is such that the silicon oxide tetrahedron ( SiO4 ) shares three out of four of its oxygen atoms with the central octahedral sheets .
39-1	4772-4775	The	abstract[280]	new[280]	_	_
39-2	4776-4787	arrangement	abstract[280]	new[280]	_	_
39-3	4788-4790	of	abstract[280]	new[280]	_	_
39-4	4791-4794	the	abstract[280]|object[281]	new[280]|giv[281]	coref	39-26[290_281]
39-5	4795-4801	sheets	abstract[280]|object[281]	new[280]|giv[281]	_	_
39-6	4802-4804	is	_	_	_	_
39-7	4805-4809	such	_	_	_	_
39-8	4810-4814	that	_	_	_	_
39-9	4815-4818	the	object[284]	new[284]	_	_
39-10	4819-4826	silicon	object|substance[283]|object[284]	new|new[283]|new[284]	_	_
39-11	4827-4832	oxide	substance[283]|object[284]	new[283]|new[284]	_	_
39-12	4833-4844	tetrahedron	object[284]	new[284]	_	_
39-13	4845-4846	(	_	_	_	_
39-14	4847-4851	SiO4	abstract	new	_	_
39-15	4852-4853	)	_	_	_	_
39-16	4854-4860	shares	_	_	_	_
39-17	4861-4866	three	abstract[286]	new[286]	_	_
39-18	4867-4870	out	abstract[286]	new[286]	_	_
39-19	4871-4873	of	abstract[286]	new[286]	_	_
39-20	4874-4878	four	abstract[286]|abstract[287]	new[286]|new[287]	ana	39-22[0_287]
39-21	4879-4881	of	abstract[286]|abstract[287]	new[286]|new[287]	_	_
39-22	4882-4885	its	abstract[286]|abstract[287]|abstract|substance[289]	new[286]|new[287]|giv|new[289]	_	_
39-23	4886-4892	oxygen	abstract[286]|abstract[287]|substance[289]	new[286]|new[287]|new[289]	_	_
39-24	4893-4898	atoms	abstract[286]|abstract[287]|substance[289]	new[286]|new[287]|new[289]	_	_
39-25	4899-4903	with	_	_	_	_
39-26	4904-4907	the	object[290]	giv[290]	_	_
39-27	4908-4915	central	object[290]	giv[290]	_	_
39-28	4916-4926	octahedral	object[290]	giv[290]	_	_
39-29	4927-4933	sheets	object[290]	giv[290]	_	_
39-30	4934-4935	.	_	_	_	_

#Text=Among various clay minerals such as kaolinite , illite , and chlorite , montmorillonite is more ideal for adsorption studies since it has a high cation exchange capacity , swelling capacity , and high surface area .
40-1	4936-4941	Among	_	_	_	_
40-2	4942-4949	various	substance[292]	new[292]	_	_
40-3	4950-4954	clay	substance|substance[292]	giv|new[292]	_	_
40-4	4955-4963	minerals	substance[292]	new[292]	_	_
40-5	4964-4968	such	substance[292]	new[292]	_	_
40-6	4969-4971	as	substance[292]	new[292]	_	_
40-7	4972-4981	kaolinite	substance[292]|substance	new[292]|new	_	_
40-8	4982-4983	,	substance[292]	new[292]	_	_
40-9	4984-4990	illite	substance[292]|substance	new[292]|new	_	_
40-10	4991-4992	,	substance[292]	new[292]	_	_
40-11	4993-4996	and	substance[292]	new[292]	_	_
40-12	4997-5005	chlorite	substance[292]|object	new[292]|new	_	_
40-13	5006-5007	,	_	_	_	_
40-14	5008-5023	montmorillonite	place	giv	ana	40-22
40-15	5024-5026	is	_	_	_	_
40-16	5027-5031	more	_	_	_	_
40-17	5032-5037	ideal	_	_	_	_
40-18	5038-5041	for	_	_	_	_
40-19	5042-5052	adsorption	abstract|abstract[298]	new|giv[298]	_	_
40-20	5053-5060	studies	abstract[298]	giv[298]	_	_
40-21	5061-5066	since	_	_	_	_
40-22	5067-5069	it	place	giv	_	_
40-23	5070-5073	has	_	_	_	_
40-24	5074-5075	a	abstract[302]	new[302]	_	_
40-25	5076-5080	high	abstract[302]	new[302]	_	_
40-26	5081-5087	cation	substance|event[301]|abstract[302]	new|new[301]|new[302]	_	_
40-27	5088-5096	exchange	event[301]|abstract[302]	new[301]|new[302]	_	_
40-28	5097-5105	capacity	abstract[302]	new[302]	_	_
40-29	5106-5107	,	_	_	_	_
40-30	5108-5116	swelling	place|abstract[304]	new|new[304]	_	_
40-31	5117-5125	capacity	abstract[304]	new[304]	_	_
40-32	5126-5127	,	_	_	_	_
40-33	5128-5131	and	_	_	_	_
40-34	5132-5136	high	abstract[306]	new[306]	_	_
40-35	5137-5144	surface	place|abstract[306]	new|new[306]	_	_
40-36	5145-5149	area	abstract[306]	new[306]	_	_
40-37	5150-5151	.	_	_	_	_
